Is early imaging a pitfall? Effect of [⁶⁸Ga]Ga-PSMA PET/CT timing after biopsy on SUVmax and adverse pathology prediction in low-to-intermediate risk prostate cancer

Enes Mustafa Kaya, Burcu Esen Akkaş, Mehmetcan Uluçay, Fuad Aghazada, Halil Lütfi Canat, Harun Özdemir, Merve Şam Özdemir, Nilsen Yıldırım Erdoğan, Meryem Kaya

Open source

DOI
10.1007/s12149-026-02288-9
Published
2026-09-26
Container
Annals of Nuclear Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12149-026-02288-9,
  title = {Is early imaging a pitfall? Effect of [⁶⁸Ga]Ga-PSMA PET/CT timing after biopsy on SUVmax and adverse pathology prediction in low-to-intermediate risk prostate cancer},
  author = {Enes Mustafa Kaya and Burcu Esen Akkaş and Mehmetcan Uluçay and Fuad Aghazada and Halil Lütfi Canat and Harun Özdemir and Merve Şam Özdemir and Nilsen Yıldırım Erdoğan and Meryem Kaya},
  year = {2026},
  journal = {Annals of Nuclear Medicine},
  doi = {10.1007/s12149-026-02288-9},
  url = {https://doi.org/10.1007/s12149-026-02288-9}
}

RIS

TY  - JOUR
TI  - Is early imaging a pitfall? Effect of [⁶⁸Ga]Ga-PSMA PET/CT timing after biopsy on SUVmax and adverse pathology prediction in low-to-intermediate risk prostate cancer
AU  - Enes Mustafa Kaya
AU  - Burcu Esen Akkaş
AU  - Mehmetcan Uluçay
AU  - Fuad Aghazada
AU  - Halil Lütfi Canat
AU  - Harun Özdemir
AU  - Merve Şam Özdemir
AU  - Nilsen Yıldırım Erdoğan
AU  - Meryem Kaya
PY  - 2026
JO  - Annals of Nuclear Medicine
DO  - 10.1007/s12149-026-02288-9
UR  - https://doi.org/10.1007/s12149-026-02288-9
ER  - 

APA

Kaya, E. M., Akkaş, B. E., Uluçay, M., Aghazada, F., Canat, H. L., Özdemir, H., Özdemir, M. Ş., Erdoğan, N. Y., & Kaya, M. (2026). Is early imaging a pitfall? Effect of [⁶⁸Ga]Ga-PSMA PET/CT timing after biopsy on SUVmax and adverse pathology prediction in low-to-intermediate risk prostate cancer. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-026-02288-9

Source records